Check Out What Whales Are Doing With REGN
Portfolio Pulse from Benzinga Insights
A significant bearish stance has been taken on Regeneron Pharmaceuticals (NASDAQ:REGN) by a large investor or institution, as indicated by unusual options trading activity. The sentiment among these big-money traders is 23% bullish and 76% bearish. The whales have been targeting a price range from $760.0 to $930.0 for REGN over the last 3 months. The current price of REGN is down -2.52% at $698.04. Several financial institutions have downgraded their ratings on REGN.
June 28, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Unusual options trading activity indicates a significant bearish stance on Regeneron Pharmaceuticals. The stock price is currently down and several financial institutions have downgraded their ratings.
The unusual options trading activity, which is heavily skewed towards bearish sentiment, indicates that large investors or institutions are expecting the price of REGN to decrease. This, combined with the recent downgrades from several financial institutions, is likely to put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100